Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
Native American tribal organizations (other)Nonprofits having 501(c)(3) statusNonprofits without 501(c)(3) statusPrivate institutions of higher educationIndividualsFor-profit organizationsSmall businessesOthersUnrestrictedState governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic/State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities
435 grants for Independent school districts
Sorted by deadline (soonest first)
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
HHS-NIH11 · PAR-25-180
Closes Oct 15, 2027
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-184
Closes Oct 15, 2027
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
HHS-NIH11 · PAR-25-120
Closes Oct 15, 2027
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-357
Closes Oct 16, 2027
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
HHS-NIH11 · PAR-25-343
Closes Oct 18, 2027
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
HHS-NIH11 · RFA-CA-27-019
Closes Oct 19, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-225
Closes Oct 20, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-059
Closes Oct 20, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-060
Closes Oct 20, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
HHS-NIH11 · PAR-25-103
Closes Oct 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
HHS-NIH11 · PAR-25-104
Closes Oct 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
HHS-NIH11 · PAR-25-353
Closes Oct 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-352
Closes Oct 25, 2027
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
HHS-NIH11 · PAR-25-149
Closes Nov 5, 2027
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-297
Closes Nov 5, 2027
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
HHS-NIH11 · PAS-25-073
Closes Nov 5, 2027
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-DA-27-004
Closes Nov 8, 2027
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-204
Closes Nov 12, 2027
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
HHS-NIH11 · PAR-24-321
Closes Nov 12, 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
HHS-NIH11 · PAR-25-216
Closes Nov 12, 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-215
Closes Nov 12, 2027
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
HHS-NIH11 · PAR-25-311
Closes Nov 15, 2027
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-336
Closes Nov 15, 2027
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
HHS-NIH11 · PAR-25-265
Closes Nov 16, 2027
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-122
Closes Nov 16, 2027